New phase 3 data at wcpghan show long-term safety, tolerability, and treatment benefits of bylvay™ (odevixibat) in pfic

– data being presented show long-term benefits of bylvay in children with pfic –
ALBO Ratings Summary
ALBO Quant Ranking